5-HT3 antagonists and ligands for dopamine D1- and autoreceptors offer new leads for antipsychotic drugs
- 28 February 1990
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 11 (2) , 49-51
- https://doi.org/10.1016/0165-6147(90)90312-v
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissueNature, 1989
- Radioligand binding studies identify 5-HT3 recognition sites in neuroblastoma cell lines and mammalian CNSTrends in Pharmacological Sciences, 1988
- Drugs and the treatment of migraineTrends in Pharmacological Sciences, 1988
- The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonistBritish Journal of Pharmacology, 1988
- Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brainBritish Journal of Pharmacology, 1987
- Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brainEuropean Journal of Pharmacology, 1987
- 5-HT3 receptors and cytotoxic drug-induced vomitingTrends in Pharmacological Sciences, 1987